14 Recruiting Advanced Hepatocellular Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Advanced Hepatocellular Carcinoma
Related Conditions
Top Recruiting Advanced Hepatocellular Carcinoma Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)
📍 Research Site — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
📍 Clinical Trial Site — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer
📍 Grady Health System — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
📍 Alta Bates Summit Medical Center-Herrick Campus — Berkeley, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Ligufalimab and Cadonilimab in Advanced Liver Cancers
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔